Nano-immunoimaging.
Journal
Nanoscale horizons
ISSN: 2055-6764
Titre abrégé: Nanoscale Horiz
Pays: England
ID NLM: 101712576
Informations de publication
Date de publication:
30 03 2020
30 03 2020
Historique:
entrez:
1
4
2020
pubmed:
1
4
2020
medline:
29
6
2021
Statut:
ppublish
Résumé
Immunoimaging is a rapidly growing field stoked in large part by the intriguing triumphs of immunotherapy. On the heels of immunotherapy's successes, there exists a growing need to evaluate tumor response to therapy particularly immunotherapy, stratify patients into responders vs. non-responders, identify inflammation, and better understand the fundamental roles of immune system components to improve both immunoimaging and immunotherapy. Innovative nanomaterials have begun to provide novel opportunities for immunoimaging, in part due to their sensitivity, modularity, capacity for many potentially varied ligands (high avidity), and potential for multifunctionality/multimodality imaging. This review strives to comprehensively summarize the integration of nanotechnology and immunoimaging, and the field's potential for clinical applications.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
628-653Subventions
Organisme : American Heart Association-American Stroke Association
ID : 18TPA34230113
Pays : United States